Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1081.15
(2.68%)
INR 1081.15
(2.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.67 Billion INR | -32.05% |
| 2022 | 6.2 Billion INR | -6.49% |
| 2021 | 6.74 Billion INR | 26.45% |
| 2020 | 4.56 Billion INR | 14.32% |
| 2019 | 4 Billion INR | 158.5% |
| 2018 | 1.72 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 799.3 Million INR | -11.58% |
| 2023 Q2 | 1.17 Billion INR | -33.68% |
| 2023 Q4 | 733.43 Million INR | -7.73% |
| 2023 FY | - INR | -32.05% |
| 2023 Q3 | 794.89 Million INR | -32.52% |
| 2023 Q1 | 1.77 Billion INR | 7.79% |
| 2022 Q3 | 1.59 Billion INR | 44.14% |
| 2022 Q1 | 1.61 Billion INR | 62.44% |
| 2022 FY | - INR | -6.49% |
| 2022 Q4 | 1.64 Billion INR | 3.19% |
| 2022 Q2 | 1.1 Billion INR | -31.57% |
| 2021 Q1 | 1.44 Billion INR | 26.65% |
| 2021 FY | - INR | 26.45% |
| 2021 Q4 | 996.77 Million INR | -60.24% |
| 2021 Q3 | 2.5 Billion INR | 73.76% |
| 2021 Q2 | 1.44 Billion INR | 0.17% |
| 2020 Q4 | 1.13 Billion INR | -28.1% |
| 2020 Q3 | 1.58 Billion INR | 47.85% |
| 2020 Q2 | 1.06 Billion INR | -16.19% |
| 2020 FY | - INR | 14.32% |
| 2020 Q1 | 1.27 Billion INR | 27.01% |
| 2019 Q2 | 1.34 Billion INR | 9.96% |
| 2019 FY | - INR | 158.5% |
| 2019 Q3 | 908 Million INR | -32.47% |
| 2019 Q4 | 1 Billion INR | 10.68% |
| 2019 Q1 | 1.22 Billion INR | 0.89% |
| 2018 Q4 | 1.21 Billion INR | 143.72% |
| 2018 Q3 | 497.26 Million INR | 0.0% |
| 2018 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 51.364% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 92.43% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 31.848% |
| Granules India Limited | 8.6 Billion INR | 45.638% |
| Indoco Remedies Limited | 2.64 Billion INR | -76.694% |
| Achyut Healthcare Limited | 524 Thousand INR | -892491.985% |
| Ajanta Pharma Limited | 12.56 Billion INR | 62.777% |
| Alkem Laboratories Limited | 24.19 Billion INR | 80.669% |
| Alpa Laboratories Limited | 86.12 Million INR | -5330.564% |
| Brooks Laboratories Limited | 41.72 Million INR | -11108.738% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -98.455% |
| Bajaj HealthCare Limited | 444.51 Million INR | -952.197% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -216.233% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 94.702% |
| Eris Lifesciences Limited | 6.98 Billion INR | 33.054% |
| FDC Limited | 4.4 Billion INR | -6.259% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 58.768% |
| Gufic Biosciences Limited | 1.48 Billion INR | -215.922% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 31.836% |
| Ipca Laboratories Limited | 13.29 Billion INR | 64.832% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -1345.985% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 5753.755% |
| Lasa Supergenerics Limited | -65.08 Million INR | 7286.819% |
| Laurus Labs Limited | 8 Billion INR | 41.579% |
| Lupin Limited | 36.96 Billion INR | 87.349% |
| Mankind Pharma Limited | 28.09 Billion INR | 83.352% |
| Medicamen Biotech Limited | 245.66 Million INR | -1803.925% |
| Medico Remedies Limited | 150.37 Million INR | -3010.283% |
| Megasoft Limited | 284.73 Million INR | -1542.667% |
| NATCO Pharma Limited | 18.79 Billion INR | 75.115% |
| Piramal Pharma Limited | 13.05 Billion INR | 64.174% |
| RPG Life Sciences Limited | 1.28 Billion INR | -264.977% |
| Sigachi Industries Limited | 883.39 Million INR | -429.454% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 96.62% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -987.019% |
| Unichem Laboratories Limited | 742.35 Million INR | -530.046% |
| Wanbury Limited | 985.49 Million INR | -374.605% |
| Windlas Biotech Limited | 781.72 Million INR | -498.319% |
| ZIM Laboratories Limited | 462.09 Million INR | -912.165% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 91.681% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 225.351% |
| Divi's Laboratories Limited | 25.43 Billion INR | 81.608% |
| Hester Biosciences Limited | 539.47 Million INR | -766.996% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -55.161% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -585.263% |
| Bal Pharma Limited | 345.59 Million INR | -1253.383% |
| Strides Pharma Science Limited | 3.76 Billion INR | -24.239% |
| Venus Remedies Limited | 711.8 Million INR | -557.091% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -19.639% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -199.093% |
| Shilpa Medicare Limited | 2.58 Billion INR | -80.727% |
| Aarti Drugs Limited | 3.24 Billion INR | -43.974% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -79.436% |
| Suven Life Sciences Limited | -992.78 Million INR | 571.12% |
| Ind-Swift Limited | 1.06 Billion INR | -339.145% |
| Valiant Laboratories Limited | 12.73 Million INR | -36615.456% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 49.895% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 265.746% |
| Themis Medicare Limited | 562.6 Million INR | -731.341% |
| Hikal Limited | 2.69 Billion INR | -73.729% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 86.64% |
| Sequent Scientific Limited | 549.8 Million INR | -750.706% |
| Novartis India Limited | 1.26 Billion INR | -268.485% |
| Wockhardt Limited | 1.08 Billion INR | -333.072% |
| Jubilant Pharmova Limited | 8 Billion INR | 41.579% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -35707.549% |
| Neuland Laboratories Limited | 4.74 Billion INR | 1.495% |
| Morepen Laboratories Limited | 1.72 Billion INR | -170.991% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -1527.27% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -2573.5% |